Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination

Main menu

Published on: September 30 2025
Source: Scientific Reports

Authors: Thidathip Wongsurawat, Piroon Jenjaroenpun, Kanokon Suwannasin, Natnicha Wankaew, Naphat Sanguansakpakdee, Thananya Amornpornviwat, Arjen M. Dondorp, Nicholas P. J. Day, Francois Nosten, Nicholas J. White, Mallika Imwong

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

© 2008 - 2025 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Discover nanopore sequencing

Explore products

Research

Techniques

Focus areas

Resources

Documentation

Nanopore Learning

Company

News & Events

Global partners

Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination